-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Reiterates Overweight on Guardant Health, Maintains $210 Price Target

Benzinga·11/20/2026 14:16:57
Listen to the news
Stephens & Co. analyst Mason Carrico reiterates Guardant Health (NASDAQ:GH) with a Overweight and maintains $210 price target.